Can psychedelics improve well-being in autism?
Science (New York, N.Y.) December 20, 2024 Rachel Nuwer 1 citation
Two new clinical trials examined the effects of psychedelic-assisted therapy in autistic adults with social anxiety. One trial found that the therapy significantly reduced social anxiety symptoms compared to a placebo, with effects lasting at least six months. The other trial reported no significant difference between the active treatment and placebo groups, though both groups showed improvement. The studies highlight both potential benefits and risks for this understudied population, including the need for careful monitoring of adverse effects.